A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed simvastatin compared to placebo, in secondary progressive multiple sclerosis, in slowing the progression of disability - MS-STAT2 A phase 3 randomised, double blind, clinical trial investigating the effectiveness of repurposed sim ...